Lyrica and Ticagrelor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lyrica (pregabalin) and Ticagrelor (ticagrelor). Common drug interactions include diabetic foot among females and myocardial infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Lyrica and Ticagrelor. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Lyrica?

Lyrica has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 261,646 Lyrica users. Check the latest studies of Lyrica.

What is Ticagrelor?

Ticagrelor has active ingredients of ticagrelor. eHealthMe is studying from 8,499 Ticagrelor users. Check the latest studies of Ticagrelor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 21, 2026

18 people who take Lyrica and Ticagrelor together, and have interactions are studied.

Lyrica and Ticagrelor drug interactions.

What are the common drug interactions of Lyrica and Ticagrelor, by gender? *:

female:

  1. Diabetic foot
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Vomiting
  4. Cardiac arrest
  5. Hypotension (abnormally low blood pressure)
  6. Blood immunoglobulin e increased
  7. Cardiac disorder
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Constipation
  10. Dyspnoea (difficult or laboured respiration)

male:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Asthenia (weakness)
  3. Dizziness
  4. Dyspnoea (difficult or laboured respiration)
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Hyperlipidaemia (presence of excess lipids in the blood)
  8. Hypertension (high blood pressure)
  9. Melaena (the passage of black, tarry stools)
  10. Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Lyrica and Ticagrelor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood immunoglobulin e increased
  2. Cardiac disorder
  3. Constipation
  4. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Headache (pain in head)
  7. Lower respiratory tract infection
  8. Lymphocyte count decreased
  9. Mean cell haemoglobin decreased (less than normal haemoglobin per red blood cell in a sample of blood)
  10. Nausea (feeling of having an urge to vomit)

50-59:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Diabetic foot
  3. Impaired work ability

60+:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Asthenia (weakness)
  3. Cardiac failure congestive
  4. Chronic kidney disease
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Dizziness
  8. Erythema (redness of the skin)
  9. Feeling hot
  10. Flatulence (flatus expelled through the anus)

What are the existing conditions these people have? *

  1. Diabetes: 7 people, 38.89%
  2. High Blood Pressure: 6 people, 33.33%
  3. Pain: 6 people, 33.33%
  4. High Blood Cholesterol: 4 people, 22.22%
  5. Chest Pain: 4 people, 22.22%
  6. Blockage Of Leg Arteries: 3 people, 16.67%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 11.11%
  9. Depression: 2 people, 11.11%
  10. Gout (uric acid crystals building up in the body): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Lyrica and Ticagrelor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lyrica and Ticagrelor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lyrica:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ticagrelor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lyrica and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ticagrelor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on pregabalin and ticagrelor (the active ingredients of Lyrica and Ticagrelor, respectively), and Lyrica and Ticagrelor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: